Blog
RSS FeedPosted by Michael Wonder on 25 Sep 2018
To include or not include drug prices in DTC advertisements
24 September 2018 - For quite some time, consumer groups, patient advocates, and even several medical professional societies have called ...
Posted by Michael Wonder on 13 Sep 2018
Beleaguered price hiking drug CEO says he wasn't defending Shkreli, he was condemning FDA
13 September 2018 - Nirmal Mulye, founder of Nostrum Pharmaceuticals, became the latest CEO in the spotlight for raising drug prices. ...
Posted by Michael Wonder on 12 Sep 2018
Trump's early efforts to trim drug costs face patient backlash
11 September 2018 - President Trump’s bid to revamp Medicare to lower drug prices for seniors is getting pushback from ...
Posted by Michael Wonder on 12 Sep 2018
Gottlieb on price gouging
12 September 2018 - Here’s something you don’t see every day: the Commissioner of the FDA took a very public ...
Posted by Michael Wonder on 11 Sep 2018
Pharma executive says he had 'moral requirement' to raise drug price 400%
11 September 2018 - A pharmaceutical company executive defended his company's recent 400% drug price increase, telling the Financial Times that ...
Posted by Michael Wonder on 06 Sep 2018
Hospitals are fed up with drug companies, so they’re starting their own
6 September 2018 - A group of major American hospitals, battered by price spikes on old drugs and long-lasting shortages ...
Posted by Michael Wonder on 29 Aug 2018
Surprise! Trump might actually lower drug prices.
29 August 2018 - Surprise! The Trump administration is actually making progress to reduce drug prices, and not just by ...
Posted by Michael Wonder on 28 Aug 2018
You may start seeing drug prices in ads, but will you understand the point?
28 August 2018 - Late last week, the U.S. Senate passed an amendment to the spending bill that would require ...
Posted by Michael Wonder on 27 Aug 2018
FDA mandated listing of drug prices in ads would flunk legal and constitutional tests
27 August 2018 - We've read with amusement the recent, overblown claims of some constitutional-law commentators and even U.S. Supreme Court ...
Posted by Michael Wonder on 23 Aug 2018
FDA's new generic EpiPen approval exemplifies progress on drug price reform
23 August 2018 - Last week, FDA Commissioner Scott Gottlieb announced the approval of the first generic version of EpiPen, an ...
Posted by Michael Wonder on 13 Aug 2018
Amicus sets $315,000 price for new Fabry disease treatment
13 August 2018 - Amicus Therapeutics on Monday set an average price of $315,000 per year for its newly approved Fabry ...
Posted by Michael Wonder on 12 Aug 2018
Alnylam prices first gene silencing drug at $450,000 per patient, but offers money-back guarantee
10 August 2018 - This morning, after 16 years and $2.5 billion in investment, the Cambridge, Massachusetts-based company Alnylam finally ...
Posted by Michael Wonder on 09 Aug 2018
Americans fund most of the world’s drug research. Here’s how Trump can end that.
9 August 2018 - President Donald Trump recently released an ambitious, 44-page plan to drive down prescription drug prices. The ...
Posted by Michael Wonder on 17 Jul 2018
Congress ready to forbid drug price 'gag clauses' against pharmacies
16 July 2018 - Senator Susan Collins of Maine on Monday said Congress is ready and able to forbid “gag ...
Posted by Michael Wonder on 13 Jun 2018
AMCP applauds FDA for final guidance on payer and manufacturer communications to improve patient access to emerging therapies
13 June 2018 - The Academy of Managed Care Pharmacy commends the U.S. FDA for issuing final guidance that clarifies ...